Tumor lysis syndrome associated with weekly paclitaxel treatment in a case with ovarian cancer.

[1]  S. Waggoner,et al.  Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study. , 2006, Gynecologic oncology.

[2]  J. Chan,et al.  Patients with malignancy requiring urgent therapy: CASE 3. Tumor lysis syndrome associated with chemotherapy in ovarian cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Ç. Ulukuş,et al.  Rapid Tumor Lysis Syndrome in a Patient with Metastatic Colon Cancer as a Complication of Treatment with 5-Fluorouracil/Leucoverin and Irinotecan , 2004, Tumori.

[4]  M. Kurt,et al.  Tumor lysis syndrome following a single dose of capecitabine , 2004, The Annals of pharmacotherapy.

[5]  W. Mcguire.  Current status of taxane and platinum-based chemotherapy in ovarian cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Sørensen,et al.  Acute tumor lysis syndrome in solid tumors—a case report and review of the literature , 2003, Cancer Chemotherapy and Pharmacology.

[7]  I. Haznedaroglu,et al.  Acute tumor lysis syndrome associated with paclitaxel , 1997, The Annals of pharmacotherapy.

[8]  J. Bar-ziv,et al.  Tumor Lysis Syndrome in Nonhematologic Malignancies: Report of a Case and Review of the Literature , 1994, American journal of clinical oncology.

[9]  J. Thigpen,et al.  Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  B. Fallon,et al.  Tumor lysis syndrome after combination chemotherapy for ovarian cancer. , 1993, Medical and pediatric oncology.